JERUSALEM, March 28, 2022 /PRNewswire/ — Alpha Tau Medical Ltd. (Nasdaq: DRTS) (Nasdaq: DRTSW), (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported full year 2021 financial results and provided a corporate update.
Read more here.
![[Arbe Robotics in PR Newswire] Arbe Robotics Continues to Drive Next-generation Autonomous Vehicle Sensing Technology With $10 Million Capital Raise](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
